Back to News
Market Impact: 0.43

Mizuho raises Micron stock price target to $800 on strong pricing

MUBAC
Analyst InsightsAnalyst EstimatesArtificial IntelligenceTechnology & InnovationCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookProduct Launches
Mizuho raises Micron stock price target to $800 on strong pricing

Mizuho raised Micron’s price target to $800 from $740 while maintaining an Outperform rating, citing strong NAND and DRAM pricing into 2H 2026 and 2027. The firm sees AI server demand, HBM and enterprise SSD ramp-ups, and potential supply constraints as tailwinds; Micron’s revenue has surged 86% over the last 12 months and the stock is already up 593% year over year. Additional bullish analyst actions include BofA’s $950 target and DA Davidson’s $1,000 target.

Analysis

The market is starting to price Micron less like a cyclical memory supplier and more like a leveraged call option on AI server buildouts with a supply discipline overlay. The key second-order effect is that higher HBM and enterprise SSD demand does not just lift Micron’s mix; it tightens adjacent NAND availability, which can keep ASPs firm even if unit demand normalizes. That matters because the next leg of earnings power may come from margin durability, not just revenue growth. The more interesting read-through is competitive. If AI server demand stays strong into 2027, the winners are the vendors with the best process migration and constrained capacity, while weaker DRAM/NAND players are forced to chase share into a tightening market or accept lower utilization. For downstream buyers, especially hyperscalers and OEMs, the risk is delayed procurement and inventory discipline reasserting itself once lead times extend, which can create a short, violent burst in orders followed by a digestion phase. The consensus may still be underestimating how reflexive this can get. As sell-side targets ratchet higher, equity capital access improves, equipment suppliers tighten, and capex stays elevated longer, extending the supply response and potentially delaying the next downcycle. The main reversal risk is not demand collapsing immediately; it is a faster-than-expected normalization in HBM capacity or a sudden demand pause from hyperscalers after 1H26 inventory build, which would hit the stock before it shows up in reported numbers. BAC is only a secondary beneficiary here, mainly through broader AI-linked market sentiment rather than direct earnings sensitivity, so any move in the bank name should be viewed as beta, not alpha. The true trade is within semis and memory supply chain exposure, where dispersion should widen as investors separate structural AI content winners from pure cyclical flashbacks.